Literature DB >> 8615787

Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver.

F Rencurel1, G Waeber, B Antoine, F Rocchiccioli, P Maulard, J Girard, A Leturque.   

Abstract

Previous studies have shown that glucose increases the glucose transporter (GLUT2) mRNA expression in the liver in vivo and in vitro. Here we report an analysis of the effects of glucose metabolism on GLUT2 gene expression. GLUT2 mRNA accumulation by glucose was not due to stabilization of its transcript but rather was a direct effect on gene transcription. A proximal fragment of the 5' regulatory region of the mouse GLUT2 gene linked to a reporter gene was transiently transfected into liver GLUT2-expressing cells. Glucose stimulated reporter gene expression in these cells, suggesting that glucose-responsive elements were included within the proximal region of the promoter. A dose-dependent effect of glucose on GLUT2 expression was observed over 10 mM glucose irrespective of the hexokinase isozyme (glucokinase K(m) 16 mM; hexokinase I K(m) 0.01 mM) present in the cell type used. This suggests that the correlation between extracellular glucose and GLUT2 mRNA concentrations is simply a reflection of an activation of glucose metabolism. The mediators and the mechanism responsible for this response remain to be determined. In conclusion, glucose metabolism is required for the proper induction of the GLUT2 gene in the liver and this effect is transcriptionally regulated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615787      PMCID: PMC1217142          DOI: 10.1042/bj3140903

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Evidence for a transient inhibitory effect of insulin on GLUT2 expression in the liver: studies in vivo and in vitro.

Authors:  C Postic; R Burcelin; F Rencurel; J P Pegorier; M Loizeau; J Girard; A Leturque
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

2.  The effects of hyperinsulinemia and hyperglycemia on GLUT4 and hexokinase II mRNA and protein in rat skeletal muscle and adipose tissue.

Authors:  C Postic; A Leturque; F Rencurel; R L Printz; C Forest; D K Granner; J Girard
Journal:  Diabetes       Date:  1993-06       Impact factor: 9.461

3.  Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters.

Authors:  D Melloul; Y Ben-Neriah; E Cerasi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue. A role for glucose 6-phosphate.

Authors:  F Foufelle; B Gouhot; J P Pégorier; D Perdereau; J Girard; P Ferré
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

5.  Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose.

Authors:  K Yasuda; Y Yamada; N Inagaki; H Yano; Y Okamoto; K Tsuji; H Fukumoto; H Imura; S Seino; Y Seino
Journal:  Diabetes       Date:  1992-01       Impact factor: 9.461

6.  Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice.

Authors:  B Antoine; F Levrat; V Vallet; T Berbar; N Cartier; N Dubois; P Briand; A Kahn
Journal:  Exp Cell Res       Date:  1992-05       Impact factor: 3.905

7.  Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism.

Authors:  S M Brichard; J C Henquin; J Girard
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

8.  Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2.

Authors:  S M Brichard; B Desbuquois; J Girard
Journal:  Mol Cell Endocrinol       Date:  1993-02       Impact factor: 4.102

9.  Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats.

Authors:  R Burcelin; M Eddouks; J Kande; R Assan; J Girard
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

10.  GLUT2 expression and function in beta-cells of GK rats with NIDDM. Dissociation between reductions in glucose transport and glucose-stimulated insulin secretion.

Authors:  M Ohneda; J H Johnson; L R Inman; L Chen; K Suzuki; Y Goto; T Alam; M Ravazzola; L Orci; R H Unger
Journal:  Diabetes       Date:  1993-07       Impact factor: 9.461

View more
  32 in total

1.  Transcriptional regulation of the human asparagine synthetase gene by carbohydrate availability.

Authors:  I P Barbosa-Tessmann; V L Pineda; H S Nick; S M Schuster; M S Kilberg
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

2.  Corticosterone alters materno-fetal glucose partitioning and insulin signalling in pregnant mice.

Authors:  O R Vaughan; H M Fisher; K N Dionelis; E C Jeffreys; J S Higgins; B Musial; A N Sferruzzi-Perri; A L Fowden
Journal:  J Physiol       Date:  2015-01-29       Impact factor: 5.182

3.  Prevalent role of the insulin receptor isoform A in the regulation of hepatic glycogen metabolism in hepatocytes and in mice.

Authors:  Sabela Diaz-Castroverde; Selene Baos; María Luque; Marianna Di Scala; Gloria González-Aseguinolaza; Almudena Gómez-Hernández; Nuria Beneit; Oscar Escribano; Manuel Benito
Journal:  Diabetologia       Date:  2016-09-07       Impact factor: 10.122

Review 4.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

5.  Karyopherin alpha2: a control step of glucose-sensitive gene expression in hepatic cells.

Authors:  Ghislaine Guillemain; Maria J Muñoz-Alonso; Aurélia Cassany; Martine Loizeau; Anne-Marie Faussat; Anne-Françoise Burnol; Armelle Leturque
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

6.  TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe ⁻/⁻ mice.

Authors:  B A Di Bartolo; J Chan; M R Bennett; S Cartland; S Bao; B E Tuch; M M Kavurma
Journal:  Diabetologia       Date:  2011-10-01       Impact factor: 10.122

7.  Transport, metabolism, and endosomal trafficking-dependent regulation of intestinal fructose absorption.

Authors:  Chirag Patel; Veronique Douard; Shiyan Yu; Nan Gao; Ronaldo P Ferraris
Journal:  FASEB J       Date:  2015-06-12       Impact factor: 5.191

8.  cAMP prevents the glucose-mediated stimulation of GLUT2 gene transcription in hepatocytes.

Authors:  F Rencurel; G Waeber; C Bonny; B Antoine; P Maulard; J Girard; A Leturque
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

9.  Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucose-responsive synthetic promoter.

Authors:  Jaeseok Han; Brienne McLane; Eung-Hwi Kim; Ji-Won Yoon; Hee-Sook Jun
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

10.  The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.

Authors:  Kyung-Chae Jeong; Kyung-Ohk Ahn; Byung Il Lee; Chang-Hoon Lee; Soo-Youl Kim
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.